What's new

Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised

Jun 16, 2025 - 16:25
 0
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Spevigo, spesolimab, Date of authorisation: 09/12/2022, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Xbryk, denosumab, Date...

Next Article

Human medicines European public assessment report (EPAR): Foclivia, pandemic inf...

Related Posts

EMEA-003567-PIP01-23

EMEA-003567-PIP01-23

Jun 11, 2025  0

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Xenpozyme, olipudase alfa, Date of authorisation: 24/06/2022, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0